
    
      Candidate with bipolar depression will be screened after signing informed consent. Those who
      meet the selection criteria will be treated with daily rTMS for 3 weeks and be followed-up at
      2 weeks. Participants will keep their ongoing medication unless a medication significantly
      increases the possibility of seizure. They must be on the same dose of antidepressant
      medication for least 4 weeks without improvement of symptoms before being recruited into the
      study. Mood and other observed mental status will be measured by standard psychological
      scales.
    
  